Lymphedema in Chronic Venous Insufficiency and Physical Procedures

Acta Medica Saliniana 01/2010;
Source: DOAJ

ABSTRACT Lymphedema is difficult, chronic, progressive, and prolonged illness with an uncertain therapeutic outcome. Lymphedema in chronic venous insufficiency (CVI), is by its ethiology a secundary illness, resulting from the dysfunction of the lymphatic and depending on the degree of CVI. This lymphedema can be transitory or persistent, acute or chronic with or without pathological changes in skin. CVI lymphedema occurs as a result of venous hypertension i.e. pathological reflux of venous blood and an increase in the mean capillary pressure in microcirculation of skin venules, which causes the venous route. The venous route impedes lymph reabsorption which upon the exhaustion of compensatory mechanisms leads to the lymph route and the occurrence of clinical lymphedema. Lymphedema therapy in CVI is directly dependent on the treatment of CVI, but to date these disorders are treated but not cured and it is correct to talk about treatment or help. Physical treatments include the application of: physical procedures such as vacusac, vasculator, magnetic, electrical, dosed kinezitherapy, laser, hyperbaric oxygen therapy (HBOT), thermomineral water of indifferent water temperature. Physical therapy contributes to the improvement and development of collateral flow and improved venous drainage with venous insufficiency. Clinically there is decrease in edema, improved trophic, reduced hyperpigmentation, reductions in dermatoflebosclerotic changes, reduced pain which ultimately improves the quality of life of these patients.

1 Follower
199 Reads
  • [Show abstract] [Hide abstract]
    ABSTRACT: This paper reviews current knowledge and hypotheses about the physiology of lymph production and lymph flow and the aetiology and classification of lymphoedema. One of the earlier contributions in the 1930's by Allen suggested that primary lymphoedema was caused by congenital underdevelopment of lymph vessels. At that time he described two clinical varieties (congenital and praecox) but later suggested a further subdivision into inflammatory and non-inflammatory types of lymphoedema. Kinmonth in 1957 produced the first clinical classification dividing all cases into primary or secondary lymphoedema but at that time gave no indication as to the cause of the primary variety. In the 1950's Kinmonth also developed a radiological classification which has contributed considerably to our knowledge of the anatomical abnormalities of the lymphatic system in primary lymphoedema. However, despite the widespread use of Kinmonth's classification the lymphographic appearances in primary lymphoedema give little or no clue to the aetiology of the disease process. The aetiology of primary lymphoedema is not known. There are various descriptive classifications based on age of onset and radiological findings for instance, but none attempts to explain the pathophysiology of the disease. We have therefore described our current knowledge of the known physiology and the potential abnormalities of the collection and passage of lymph from the interstitial space to the blood system. Based on this we have presented a simple classification of the aetiology of lymphoedema. Thus primary lymphoedema may be defined as lymphoedema caused by a primary abnormality or disease of the lymph conducting elements of the lymph vessels or lymph nodes. Secondary lymphoedema is oedema caused by disease in the nodes or vessels that began elsewhere (e.g., neoplasia or filariasis), or lymphocytic proliferative disorders such as Hodgkin's disease or following surgical extirpation of lymph nodes or vessels. There are three groups of primary lymphoedema in which the functional abnormality and its cause are known; namely (a) large vessel abnormalities such as congenital aplasia of the thoracic duct or cysterna chyli, (b) congenital lymphatic valvular incompetence or congenital aplasia and (c) lymph node fibrosis. The remainder are characterised by a reduced number of lymphatics on lymphography. Such patients can be described as having obliterated lymphatics. If they present within a few years of birth they were probably born with too few lymphatics. However, those who present later in life may have acquired obliterative disease, the cause of which is still obscure.(ABSTRACT TRUNCATED AT 400 WORDS)
    The Journal of cardiovascular surgery 01/1985; 26(2):91-106. · 1.46 Impact Factor
  • British Journal of Surgery 07/1957; 45(189):1-9. DOI:10.1002/bjs.18004518902 · 5.54 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: A common challenge for primary care physicians is to determine the cause and find an effective treatment for leg edema of unclear etiology. We were unable to find existing practice guidelines that address this problem in a comprehensive manner. This article provides clinically oriented recommendations for the management of leg edema in adults. We searched on-line resources, textbooks, and MEDLINE (using the MeSH term, "edema") to find clinically relevant articles on leg edema. We then expanded the search by reviewing articles cited in the initial sources. Our goal was to write a brief, focused review that would answer questions about the management of leg edema. We organized the information to make it rapidly accessible to busy clinicians. The most common cause of leg edema in older adults is venous insufficiency. The most common cause in women between menarche and menopause is idiopathic edema, formerly known as "cyclic" edema. A common but under-recognized cause of edema is pulmonary hypertension, which is often associated with sleep apnea. Venous insufficiency is treated with leg elevation, compressive stockings, and sometimes diuretics. The initial treatment of idiopathic edema is spironolactone. Patients who have findings consistent with sleep apnea, such as daytime somnolence, loud [corrected] snoring, or neck circumference >17 inches, should be evaluated for pulmonary hypertension with an echocardiogram. If time is limited, the physician must decide whether the evaluation can be delayed until a later appointment (eg, an asymptomatic patient with chronic bilateral edema) or must be completed at the current visit (eg, a patient with dyspnea or a patient with acute edema [<72 hours]). If the evaluation should be conducted at the current visit, the algorithm shown in Figure 1 could be used as a guide. If the full evaluation could wait for a subsequent visit, the patient should be examined briefly to rule out an obvious systemic cause and basic laboratory tests should be ordered for later review (complete blood count, urinalysis, electrolytes, creatinine, blood sugar, thyroid stimulating hormone, and albumin).
    The Journal of the American Board of Family Medicine 03/2006; 19(2):148-60. DOI:10.3122/jabfm.19.2.148 · 1.98 Impact Factor
Show more


199 Reads
Available from